Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization
- PMID: 1764497
- DOI: 10.1007/BF03324024
Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization
Abstract
The Syst-Eur Trial is a concerted action of the European Community's Medical and Health Research Programme. The trial is carried out in consultation with the World Health Organization, the International Society of Hypertension, the European Society of Hypertension and the World Hypertension League. This article describes the objectives and the protocol of Syst-Eur, a multicentre trial designed by the European Working Party on High Blood Pressure in the Elderly (EWPHE), to test the hypothesis that antihypertensive treatment of elderly patients with isolated systolic hypertension results in a significant change in stroke morbidity and mortality. Secondary endpoints include cardiovascular events, such as myocardial infarction and congestive heart failure. To be eligible patients must be at least 60 years old and have a systolic blood pressure averaging 160-219 mmHg with a diastolic pressure less than 95 mmHg. Patients must give their informed consent and be free of major cardiovascular and non-cardiovascular diseases at entry. The patients are randomized to active treatment or placebo. Active treatment consists of nitrendipine (10-40 mg/day), combined with enalapril (5-20 mg/day) and hydrochlorothiazide (12.5-25 mg/day), as necessary. The patients of the control group receive matching placebos. The drugs (or matching placebos) are stepwise titrated and combined in order to reduce systolic blood pressure by 20 mmHg at least to a level below 150 mmHg. Morbidity and mortality are monitored to enable an intention-to-treat and per-protocol comparison of the outcome in the 2 treatment groups. A one-year pilot trial (1989) showed that the protocol is practicable. The Ethics Committee therefore decided to start the definite study (1990), in which randomized patients will be followed for 5 years. Recruitment of new centres and of the required 3,000 patients will last 3 years (until 1993).
Similar articles
-
Trials in elderly patients with isolated systolic hypertension.Chin Med J (Engl). 1992 May;105(5):364-8. Chin Med J (Engl). 1992. PMID: 1499364 Clinical Trial.
-
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.Lancet. 1997 Sep 13;350(9080):757-64. doi: 10.1016/s0140-6736(97)05381-6. Lancet. 1997. PMID: 9297994 Clinical Trial.
-
Treatment of isolated systolic hypertension in the elderly: the Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):491-7. doi: 10.3109/10641969909060982. Clin Exp Hypertens. 1999. PMID: 10423075 Clinical Trial.
-
Risk reduction associated with lowering systolic blood pressure: review of clinical trial data.Am Heart J. 1999 Sep;138(3 Pt 2):225-30. doi: 10.1016/s0002-8703(99)70314-5. Am Heart J. 1999. PMID: 10467217 Review.
-
[Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].Drugs. 2000;59 Spec No 2:25-37. Drugs. 2000. PMID: 11002856 Review. French.
Cited by
-
Calcium channel blockers versus other classes of drugs for hypertension.Cochrane Database Syst Rev. 2022 Jan 9;1(1):CD003654. doi: 10.1002/14651858.CD003654.pub6. Cochrane Database Syst Rev. 2022. PMID: 35000192 Free PMC article.
-
Treatment of the older hypertensive: paradigms, practices, and proofs.Cardiovasc Drugs Ther. 1992 Dec;6(6):565-9. doi: 10.1007/BF00052555. Cardiovasc Drugs Ther. 1992. PMID: 1292574 Review.
-
Blood pressure and ageing.Postgrad Med J. 2007 Feb;83(976):109-14. doi: 10.1136/pgmj.2006.048371. Postgrad Med J. 2007. PMID: 17308214 Free PMC article. Review.
-
[Prevention of arteriosclerosis. Importance of the treatment of arterial hypertension].Z Kardiol. 2005;94 Suppl 3:III/56-65. doi: 10.1007/s00392-005-1308-9. Z Kardiol. 2005. PMID: 16258793 German.
-
Lifestyle factors in hypertension drug research: systematic analysis of articles in a leading cochrane report.Int J Hypertens. 2014;2014:835716. doi: 10.1155/2014/835716. Epub 2014 Jan 28. Int J Hypertens. 2014. PMID: 24678418 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical